Skip to main content
. 2015 Apr 25;34(1):38. doi: 10.1186/s13046-015-0157-2

Figure 1.

Figure 1

Synergistic effects of combination treatment with EPD on ovarian cancer cell lines and normal fibroblasts. Relative viability is shown for each single compound. E: EPD, C: cisplatin, T: paclitaxel. Synergism was observed between EPD and paclitaxel for SK-OV-3 and JC, whereas for JC-pl the combination of EPD and cisplatin was found to be synergistic.